Zera Health review

Zera names its compounding pharmacy outright and identifies it as a 503A facility, which is the only such disclosure here and genuinely counts for something. Everything about the pricing counts against it. Three different figures are advertised for the microdose across the homepage, the product hero and the plan table, and the checkout charges a first month and a standing rate that match none of them — a standing rate identical to standard semaglutide, so the low dose carries no price benefit at all. The microdose page is a copy of the semaglutide page down to its intake link.

Vs median

$30/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Same price at every dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Flat at every dose

Price last updated

August 2026

Zera Health dispenses through a 503A facility. No bloodwork is required before you start. A clinician review is included in the price.

Zera Health is a Florida-contact telehealth storefront selling compounded GLP-1s alongside brand-name products, plus sermorelin, NAD+, B12 combinations, hormone therapy, sexual-health medication and hair products. Care is asynchronous: a twelve-step intake form on the site itself feeds a clinical backend and a CRM, with payment through a card processor and a separate patient portal. The site states that it is a technology platform and not a medical services provider, and that compounded medications are prepared by a named 503A compounding pharmacy — the only pharmacy named anywhere here. It claims licensed physicians in 50 states, free shipping, no insurance, and free unlimited consultations and messaging. It publishes no legal entity name.

None of Zera's advertised microdose prices are purchasable. The homepage, the product hero and the product page's own plan table each quote a different figure, and the checkout charges a first month and a standing rate that match none of them

• The microdose costs exactly what standard compounded semaglutide costs — the identical first charge and the identical standing rate in Zera's own checkout — so there is no price benefit to the lower dose at all
• The microdose page is a copy of the semaglutide page: the same vial description, the same plan table, the same FAQ, and a call to action that links to the standard semaglutide intake rather than to any microdose product
• Sale banners on the homepage and the treatment pages advertise deadlines that have already passed and are still displayed
• The intake page hardcodes several promo codes into public page source running up to half off, so any quoted price is arbitrary to whoever reads the source
• The public intake page exposes live backend credentials in client-side source on a site that advertises itself as HIPAA secure and encrypted
• No legal entity is published anywhere, and the terms page covers messaging terms only
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

Zera Health is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• Microdosing semaglutide
• Is compounded GLP-1 safe?
• The true annual cost of a plan
• What a flat price costs at a low dose